2nd Quarter - Report

MAYO CLINIC for MAYO CLINIC

Firm
Client
Income
—
Expenses
$140,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Railroads RRR

High Speed Rail; Freight Rail Corridor

LobbyistCovered position, as disclosed
JENNIFER MALLARD —

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Transportation, Dept of (DOT); SENATE; HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

Lab Payments; Lab Oversight; Research Funding

LobbyistCovered position, as disclosed
JENNIFER MALLARD —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Transportation, Dept of (DOT); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Health Issues HCR

Hospital Payments; Physicain Paymets; Healthcare Grants; Medical Record Privacy; Telemedicine; ICD-10

LobbyistCovered position, as disclosed
JENNIFER MALLARD —

Contacted: Transportation, Dept of (DOT); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Medicare/Medicaid MMM

Medicare Physician Paymets; Medicare Hospital Payments; Medicare Clinical Lab Payments; Teaching Hospital Payments; ACOs; CMS CMMI; Quality Issues; Telemedicine; Transparancy

LobbyistCovered position, as disclosed
JENNIFER MALLARD —

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Transportation, Dept of (DOT); HOUSE OF REPRESENTATIVES; SENATE

Science/Technology SCI

Remote Care Technologies; Medical Device Technologies; New Diagnostic Tests

LobbyistCovered position, as disclosed
JENNIFER MALLARD —

Contacted: Health & Human Services, Dept of (HHS); SENATE; Transportation, Dept of (DOT); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.